Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect via Multi-functional Nanoparticles for Orthotopic Non-Small Cell Lung Cancer Treatment
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 9 (20) , 5886-5898
Abstract
Targeting tumor angiogenesis pathway via VEGF siRNA (siVEGF) has shown great potential in treating highly malignant and metastatic non-small cell lung cancer (NSCLC). However, anti-angiogenic monotherapy lacked sufficient antitumor efficacy which suffered from malignant tumor proliferation. Therefore, the combined application of siVEGF and chemotherapeutic agents for simultaneous targeting of tumor proliferation and angiogenesis has been a research hotspot to explore a promising NSCLC therapy regimen.Keywords
This publication has 44 references indexed in Scilit:
- Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticlesBiomaterials, 2013
- Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and MetastasisClinical Cancer Research, 2012
- Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drugJournal of Controlled Release, 2011
- Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered NanoparticlesPLOS ONE, 2011
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLCOncoTargets and Therapy, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Nanoparticles for Drug Delivery Prepared from Amphiphilic PLGA Zwitterionic Block Copolymers with Sharp Contrast in Polarity between Two BlocksAngewandte Chemie International Edition, 2010
- Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitorsThrombosis and Haemostasis, 2003